The obvious and inevitable risk of the proposal is that companies will act to innoculate their larger and more lucrative market by not launching or significantly delaying the launch of new medicines in Australia. They may even be forced to consider removing already reimbursed medicines. …
Latest Video
New Stories
-
The COVID-19 vaccine manufacturing and supply deals
August 7, 2020 - - Latest News -
Greg Hunt moves to extend industry agreements
August 7, 2020 - - Latest News -
CSL says it is now 'exploring ways' to manufacture another vaccine
August 7, 2020 - - Latest News -
Goldman Sachs: US will be first because it has invested the most
August 6, 2020 - - Latest News -
What is the strategy? Is there a strategy?
August 6, 2020 - - Comment -
Neurohack brainstorms solutions for young people with SMA
August 6, 2020 - - Latest News -
Ventolin with dose counter makes it to the PBS
August 6, 2020 - - Latest News